Shopping Cart
Remove All
Your shopping cart is currently empty
Apimostinel (NRX-1074; AGN-241660) is a partial agonist of the NMDA receptor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,490 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,940 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,800 | 6-8 weeks | 6-8 weeks |
| Description | Apimostinel (NRX-1074; AGN-241660) is a partial agonist of the NMDA receptor. |
| In vitro | Apimostinel (NRX-1074) modulates the NMDA receptor similarly to GLYX-13 but includes a synthetic amino acid modification that enhances its potency and oral bioavailability[1]. |
| In vivo | In preclinical models, both compounds demonstrate high efficacy in treating various CNS disorders[1]. |
| Synonyms | NRX-1074, AGN-241660 |
| Molecular Weight | 503.59 |
| Formula | C25H37N5O6 |
| Cas No. | 1421866-48-9 |
| Smiles | C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |
| Relative Density. | 1.330 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 155 mg/mL (307.79 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (9.93 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.